W P Drake|M R Mardiney - JoVE Visualize

Showing results (1-10 of 33) with videos related to

Pageof 4

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1975

Complement-mediated alteration of antibody specificity in vivoW P Drake, M R Mardiney

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 10, 1976

Latent homology of murine lymphoid antigens revealed through the complement mediated absorption of xenogeneic antiserumW P Drake, G C Roberts, M R Mardiney

Journal of the National Cancer Institute|September 1, 1976

A proper sequence for the treatment of B16 melanoma: chemotherapy, surgery, and immunotherapyW J Pendergrast, W P Drake, M R Mardiney

Journal of the National Cancer Institute|November 11, 1975

The dependence of successful immunotherapy on adequate tumor burden as shown by the treatment of AKR leukemia with poly A-poly UW J Pendergrast, W P Drake, M R Mardiney

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|January 1, 1978

Alteration of cellular ribonucleases associated with murine oncogenic virus infectionW P Drake, L M Frazier, D Sidle, et al.

Cancer Research|March 11, 1976

The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR miceW P Drake, W J Pendergrast, R E Kramer, et al.

Cancer Research|February 11, 1975

Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing miceW P Drake, L P Kopyta, C C Levy, et al.

Cancer Research|November 11, 1975

Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapyW P Drake, W J Pendergrast, R E Kramer, et al.

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 11, 1975

The kinetics of the interaction of heterologous anti-tumor serum and heterologous complement in non-tumor bearing miceW P Drake, G C Roberts, W J Pendergrast, et al.

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1976

In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced deathW P Drake, D R Pokorney, L P Kopyta, et al.

Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:

Pageof 4

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1975

Complement-mediated alteration of antibody specificity in vivoW P Drake, M R Mardiney

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 10, 1976

Latent homology of murine lymphoid antigens revealed through the complement mediated absorption of xenogeneic antiserumW P Drake, G C Roberts, M R Mardiney

Journal of the National Cancer Institute|September 1, 1976

A proper sequence for the treatment of B16 melanoma: chemotherapy, surgery, and immunotherapyW J Pendergrast, W P Drake, M R Mardiney

Journal of the National Cancer Institute|November 11, 1975

The dependence of successful immunotherapy on adequate tumor burden as shown by the treatment of AKR leukemia with poly A-poly UW J Pendergrast, W P Drake, M R Mardiney

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|January 1, 1978

Alteration of cellular ribonucleases associated with murine oncogenic virus infectionW P Drake, L M Frazier, D Sidle, et al.

Cancer Research|March 11, 1976

The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR miceW P Drake, W J Pendergrast, R E Kramer, et al.

Cancer Research|February 11, 1975

Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing miceW P Drake, L P Kopyta, C C Levy, et al.

Cancer Research|November 11, 1975

Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapyW P Drake, W J Pendergrast, R E Kramer, et al.

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 11, 1975

The kinetics of the interaction of heterologous anti-tumor serum and heterologous complement in non-tumor bearing miceW P Drake, G C Roberts, W J Pendergrast, et al.

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1976

In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced deathW P Drake, D R Pokorney, L P Kopyta, et al.

Pageof 4